These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 20652684)
21. Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Lu Q; Girardi C; Zhang M; Bouhemad B; Louchahi K; Petitjean O; Wallet F; Becquemin MH; Le Naour G; Marquette CH; Rouby JJ Intensive Care Med; 2010 Jul; 36(7):1147-55. PubMed ID: 20397007 [TBL] [Abstract][Full Text] [Related]
22. Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Ziaka M; Markantonis SL; Fousteri M; Zygoulis P; Panidis D; Karvouniaris M; Makris D; Zakynthinos E Antimicrob Agents Chemother; 2013 Apr; 57(4):1938-40. PubMed ID: 23335739 [TBL] [Abstract][Full Text] [Related]
23. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii. Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664 [TBL] [Abstract][Full Text] [Related]
32. Stability of colistimethate sodium in a disposable elastomeric infusion device. Abdulla A; van Leeuwen RW; de Vries Schultink AH; Koch BC Int J Pharm; 2015; 486(1-2):367-9. PubMed ID: 25863116 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate. Li J; Milne RW; Nation RL; Turnidge JD; Smeaton TC; Coulthard K J Antimicrob Chemother; 2004 May; 53(5):837-40. PubMed ID: 15044428 [TBL] [Abstract][Full Text] [Related]
34. Placental transmission of colistimethate. MacAulay MA; Charles D; Burgess FM Clin Pharmacol Ther; 1967; 8(4):578-86. PubMed ID: 4951974 [No Abstract] [Full Text] [Related]
35. Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy. Leuppi-Taegtmeyer AB; Decosterd L; Osthoff M; Mueller NJ; Buclin T; Corti N Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478168 [TBL] [Abstract][Full Text] [Related]
36. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center. Akajagbor DS; Wilson SL; Shere-Wolfe KD; Dakum P; Charurat ME; Gilliam BL Clin Infect Dis; 2013 Nov; 57(9):1300-3. PubMed ID: 23840000 [TBL] [Abstract][Full Text] [Related]
37. Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B? Zavascki AP; Nation RL Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993859 [TBL] [Abstract][Full Text] [Related]
38. [Shedding light on the use of colistin: still gaps to be filled]. Luque S; Grau S; Berenguer N; Horcajada JP; Sorlí L; Montero MM; Salas E Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):287-96. PubMed ID: 21440335 [TBL] [Abstract][Full Text] [Related]
39. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis. Pastor M; Moreno-Sastre M; Esquisabel A; Sans E; Viñas M; Bachiller D; Asensio VJ; Pozo AD; Gainza E; Pedraz JL Int J Pharm; 2014 Dec; 477(1-2):485-94. PubMed ID: 25445528 [TBL] [Abstract][Full Text] [Related]
40. Removal of colistin during intermittent haemodialysis in two critically ill patients. Marchand S; Frat JP; Petitpas F; Lemaître F; Gobin P; Robert R; Mimoz O; Couet W J Antimicrob Chemother; 2010 Aug; 65(8):1836-7. PubMed ID: 20501487 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]